Bone Degeneration Therapeutics Market continues to expand with Amgen and UCB receiving the U.S. FDA approval for its osteoporosis medicine EVENITY
Market Overview
Bone Degeneration Therapeutics is the use of injected nutrients to promote bone growth and repair in sickle cell disease patients. Sickle Cell Disease is a hereditary blood disorder that causes the blood cells to be made primarily from a protein called Sulfate. This protein, when combined with an enzyme (Cysteine) makes a weak chain of proteins, one of which is called Sulfate. This weak sulfate chain of amino acids is what sickle cells use as their main form of fuel to move.
Request a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/94
Market Dynamics
Rising prevalence of osteoarthritis and osteoporosis is expected to drive growth of the global bone degeneration therapeutics market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), osteoarthritis affects around 32.5 million adults in the U.S. each year. According to the same source, around 78 million people are going to have some form of arthritis by 2040. Furthermore, according to the International Osteoporosis Foundation (IOF), 1 in 3 women aged 50 years and above and 1 in 5 men are expected to experience osteoporotic fractures in their lifetime. As a result of this, the adoption of various types of bone degeneration therapeutics has increased.
However, side-effects associated with the use of non-steroidal anti-inflammatory drugs such as allergic reaction, stomach ulcer, and dizziness are expected to restrain growth of the bone degeneration therapeutics market during the forecast period.
To get a Free PDF Brochure of This Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/94
Impact of COVID-19
The global bone degeneration therapeutics market witnessed a significant decline due to the outbreak of the COVID-19 pandemic. Since the outbreak of the pandemic in December 2019, many countries shut down their borders and suspended international travel temporarily. Furthermore, a major disruption in the global supply chain industry leads to slow economic activities worldwide. Key companies in the biotechnology and pharmaceutical sectors were focused on developing novel vaccines and drugs for the COVID-19, which impacted growth of the market.
Key Takeaways
- The global bone degeneration therapeutics market is expected to witness significant growth. This is owing to the launch of advanced therapeutics. For instance, in April 2019, Amgen and UCB received the U.S. Food and Drug Administration (FDA) approval for EVENITY for the treatment of osteoporosis in postmenopausal women.
- Among regions, North America is expected to witness significant growth in the global bone degeneration therapeutics market during the forecast period. This is owing to the presence of well-established healthcare infrastructure, favorable reimbursement policies, and increasing geriatric population.
- Key companies involved in the global bone degeneration therapeutics market are Abbott Laboratories, Bayer AG, Flexion Therapeutics, Inc., GlaxoSmithKline plc, Horizon Therapeutics plc, Johnson & Johnson, Novartis, Pfizer Inc., Sanofi, and Zimmer Biomet Holding.
To Direct Purchase this Premium Research Report Here: https://www.coherentmarketinsights.com/insight/buy-now/94
- Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations - Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM) - Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis - Global Bone Degeneration Therapeutics Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Bone Degeneration Therapeutics Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Bone Degeneration Therapeutics Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Bone Degeneration Therapeutics Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
8. Global Bone Degeneration Therapeutics Market, By Regions, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, By Region, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2021 – 2028
o North America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• U.S.
• Canada
o Europe
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Latin America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
o Africa
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• South Africa
• Central Africa
• North Africa
o Middle East
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• GCC
• Israel
• Rest of Middle East
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837